Skip to main content
Premium Trial:

Request an Annual Quote

Shares in Affymetrix Jump 6.95 Percent on News of Record Sales Growth

NEW YORK, Jan. 5 (GenomeWeb News) - Shares in Affymetrix were up 6.95 percent at $36.30 in late-afternoon trading after the company said sales during the fourth quarter of 2004 increased 17 percent to more than $100 million.

 

Affymetrix said that the product-related revenues were a record for the company, and investors flocked to buy the stock. The shares traded as high as $37.24 this morning.

 

As GenomeWeb News reported this morning, the microarray giant also said it has $10 million worth of orders for products it plans to release within the next six months, including new SNP-genotyping arrays and automated instrumentation.

 

The company will release its formal financial results on Jan. 26 after the stock market closes.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.